Mechanism of puromycin activation of tadpole liver glycogen synthetase.
D000818:Animals; D001001:Anura; D000242:Cyclic AMP / Q000096:biosynthesis; D003921:Diabetes Mellitus, Experimental / Q000201:enzymology; D005947:Glucose / Q000494:pharmacology; D005964:Glucosyltransferases / Q000378:metabolism*; D007328:Insulin / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008112:Liver Glycogen / Q000378:metabolism; D010179:Pancreas / Q000502:physiology*; D010180:Pancreatectomy; D010744:Phosphoric Monoester Hydrolases / Q000037:antagonists & inhibitors; D010764:Phosphorylase Kinase / Q000378:metabolism; D011691:Puromycin / Q000008:administration & dosage / Q000494:pharmacology*; D013268:Stimulation, Chemical
D007328:Insulin; D008112:Liver Glycogen; D011691:Puromycin; D000242:Cyclic AMP; D005964:Glucosyltransferases; D010764:Phosphorylase Kinase; D010744:Phosphoric Monoester Hydrolases; D005947:Glucose